American Well Corporation is a software and technology company that provides a cloud-based platform for hybrid healthcare delivery. Founded in 2006, the company enables health systems, health plans, employers, and government entities to manage digital care programs across in-person, virtual, and automated modalities. Its core offering, the Amwell Platform, supports use cases including virtual primary care, urgent care, behavioral health, chronic disease management, and specialty follow-up. The company also provides Carepoint hardware devices, such as carts and peripherals, to facilitate virtual care interactions. Through its subsidiary Amwell Medical Group, American Well operates a nationwide network of clinical entities that provides 24/7/365 provider coverage. The platform integrates with existing electronic health record systems and claims infrastructure, serving clients in the United States and internationally.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Health Information Services Homepage business.amwell.com
Sector Healthcare IR page investors.amwell.com
Tags
telehealth, virtual care, behavioral health, primary care, urgent care, chronic disease management, digital health, healthcare it, provider network, hybrid care, Amwell Platform, Carepoint, Amwell Medical Group, AMG
Press page —

Metrics

Valuation  
Market cap $ 222.787M
Market cap (USD) $ 222.787M
P/E -3.77
PEG —
P/BV 1.05
P/S 1.05
P/OCF -11.55
P/FCF -11.53
Dividend yield —
Turnover / mcap —
Returns  
ROE -35.4%
ROI -176.7%
ROIC -145.8%
Profit margin -38.4%
Growth  
Revenue growing No
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock —
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 29
Quality score -50.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue 249.325M 254.364M 259.047M 277.19M 252.789M 245.265M 148.857M
Net profit -95.7M -208.143M -675.164M -270.429M -176.334M -224.432M -87.19M
Free cash flow -65.974M -127.457M -148.535M -192.615M -142.096M -115.782M -83.23M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Share price 4.91 7.25 1.49 2.83 6.04 25.33 —
Price performance 12m -0.32 3.87 -0.47 -0.53 -0.76 — —

Filed figures

Figure Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 32.7M 45.3M 51.4M 58.4M 54.1M 71.9M 49.7M
↳ YoY growth +38.4% +13.4% +13.6% -7.2% +32.8% -30.9%
↳ 5y CAGR +17.0% +1.9%
Lease liabilities (USD) — — 13.4M 7.65M 16.6M 14.8M 11.8M 8.2M 4.52M
Cash and deposits (USD) 95.8M 54.1M 138M 942M 746M 539M 372M 228M 182M
Intangible assets (USD) — — 63.5M 55.5M 152M 135M 120M 102M 66.1M
Right-of-use assets (USD) — — 11.9M 6.61M 16.4M 13.5M 10.5M 7.2M 3.93M
Cash flow detail
Operating cash flow (USD) — -74M -81.9M -112M -142M -192M -148M -127M -66M
Purchases of property, plant and equipment (USD) — -1.91M -1.34M -3.32M -559,000 -292,000 -192,000 -119,000 -21,000
Change in receivables (cash effect) (USD) — -19.5M 803,000 -14.2M -512,000 -8.14M 3.25M -25M 12.2M
Change in inventories (cash effect) (USD) — 1.57M -592,000 -6.02M 1.6M -1.21M 2.09M 1.9M 1.17M
Change in payables (cash effect) (USD) — -787,000 1.16M -707,000 5.55M -4.78M -2.36M 159,000 -3.42M
Income taxes paid (cash effect) (USD) — — -193,000 -713,000 -1.59M -1.72M -5M -4.11M -1.97M
Share-based compensation (USD) — 7.67M 12.1M 118M 43.8M 67.7M 72.2M 47.5M 22M
Operating cash flow before change in receivables (USD) — -54.5M -82.7M -98.3M -141M -184M -152M -102M -78.2M
Free cash flow (OCF - PPE - intangibles) (USD) — -75.9M -83.2M -116M -142M -193M -149M -127M -66M
Income detail
Research and development expense (USD) — 36.3M 53.9M 84.4M 107M 138M 106M 86.1M 72.9M
↳ 5y CAGR +23.9% +9.8% -2.9%
Total comprehensive income (USD) — -51M -89.5M -229M -183M -283M -678M -213M -91.2M
Comprehensive income to owners (USD) — -51M -89.5M -229M -183M -283M — — —
Provision for credit losses (USD) — 211,000 717,000 1.65M 714,000 806,000 1.06M 7.09M 2.74M
Credit cost ratio (credit losses / average receivables) (%) — — — 4.2% 1.5% 1.5% 1.9% 11.3% 4.5%
Reported Mar 26, 2021 Mar 26, 2021 Mar 26, 2021 Mar 26, 2021 Feb 28, 2022 Feb 23, 2023 Feb 15, 2024 Feb 12, 2025 Feb 12, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

BOSTON, November 3, 2026 –Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30, 2026.

“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three,” said Dr. Ido Schoenberg, Chairman and CEO of Amwell. “Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works.

October 26, 2026

PDF Version

BOSTON, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL a leading provider of technology-enabled care, will report third quarter 2026 operating results after stock market trading hours on Tuesday, November 3.

Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.

The live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.

About Amwell Amwell offers health plans and healthcare organizations a single, comprehensive, technology-enabled care platform. We use technology to provide consumers with better access to more convenient, affordable, and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows consumers to experience unified, personalized, and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions while delivering dependable outcomes. For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Investors:

Asher Dewhurst

[email protected]

Media:

[email protected]

Search Investors

Company Logo

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, or your device, and is mostly used to make the site work as you expect. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. Blocking some types of cookies may impact your experience of the site and the services we are able to offer. By clicking ‘Accept all’, you agree to allow us to set cookies for site navigation, usage analysis, and marketing; and to monitor, collect, use, and transmit to and share with third-party vendors, information such as device data, website activity, and information you provide. Privacy Policy

Accept All

Manage Consent Preferences

Strictly Necessary Cookies

Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Cookies Details

Performance Cookies

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Cookie List

Clear

  • checkbox label label

Apply Cancel

Leg.Interest

checkbox label label

checkbox label label

checkbox label label

Reject All

Powered by Onetrust

October 14, 2026

PDF Version

A fully funded digital mental health benefit integrated into Discovery Health’s existing care pathways and member app reached 22,000 member activations in its first 12 months, with 90% user satisfaction, clinically significant improvement in depression and anxiety, and 6% lower adjusted mental-health-related in-hospital costs in the year after use

BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health’s use of SilverCloud® by Amwell® to deliver a fully funded digital mental health benefit in South Africa. The case study examines the three questions health plans ask of digital care: whether members will use it, whether it improves their health, and what it does to costs.

In the program's first 12 months, 22,000 Discovery Health members activated the benefit. Members with moderate, moderately severe or severe depression at baseline, and members with moderate or severe anxiety, showed clinically significant improvement rates of 60% to 78% across depression and anxiety measures, depending on severity at baseline. 90% of surveyed users were satisfied, and the case study reports 6% lower adjusted mental-health-related in-hospital costs in the year after use, after adjusting for baseline experience and confounding factors.

Activation first: embedded in the benefit members already use

Discovery Health introduced the benefit in late 2023 as South Africa's first funded digital therapeutic benefit for mental health. Rather than launching a standalone digital service, Discovery Health built SilverCloud directly into its existing mental healthcare benefit, clinical referral pathway and member experience. Eligible adult members with mild-to-moderate depression or anxiety can be referred by a GP or psychologist, activate the benefit through the Discovery Health App and begin structured internet-based Cognitive Behavioral Therapy, or iCBT.

Members receive evidence-based digital CBT content alongside personalized written guidance and feedback from trained human supporters, who monitor progress and help members stay engaged. Referring healthcare professionals remain part of the care pathway throughout.

The findings also show where activation was highest. Activation was approximately three times higher among members already using other digital health services associated with their medical scheme membership, and approximately 30% higher among members newly diagnosed with depression than among those diagnosed one year or more earlier.

“Introducing South Africa's first funded digital therapeutic for mental health is a milestone we are genuinely proud of - not because of what it represents for Discovery Health, but because of what it means for our members. iCBT is a clinically validated, effective treatment that puts members in the driver's seat of their own mental health recovery, on their own terms and in their own time,” said Dr. Noluthando Nematswerani, Chief Clinical Officer, Discovery Health.

Outcomes: clinical improvement, satisfaction and lower costs

Findings presented in the case study include:

  • 22,000 member activations within the first 12 months

  • For members with moderate, moderately severe, and severe depression at baseline, clinically significant improvement rates of 60%, 71%, and 78%, respectively; measured using the Patient Health Questionnaire-9, or PHQ-9, for depression

  • For members with moderate and severe anxiety at baseline, clinically significant improvement rates of 60% and 66%, respectively; measured using the Generalized Anxiety Disorder-7, or GAD-7, assessment for anxiety

  • 90% user satisfaction among surveyed members

  • 6% lower adjusted mental-health-related in-hospital costs in the year after use, after adjusting for baseline experience and confounding factors

  • Approximately 3x higher activation among members already engaged with other digital health services

  • Approximately 30% higher activation among members newly diagnosed with depression compared with those diagnosed one year or more earlier

“Discovery Health has demonstrated what can be achieved when evidence-based digital treatment is embedded into an existing mental health benefit, clinical referral pathway, and member experience,” said Ian Carr, Vice President, International Behavioural Health at Amwell. “Reaching 22,000 activations in 12 months, alongside strong clinical outcomes, high satisfaction and lower adjusted in-hospital costs, demonstrates the potential for guided digital CBT to expand access while supporting the long-term sustainability of mental healthcare systems.”

“These results point to a practical model for health plans: fund digital care as part of the existing benefit, embed access in the digital and clinical pathways members already use, keep the trusted clinician referral, combine on-demand treatment with personalized human support, and measure the clinical and financial outcomes so the plan can show what it achieved,” said Michael Miller, Senior Vice President at Amwell. “This approach aligns with what the Amwell Platform enables for U.S. health plans.”

The full case study, “Discovery Health reached 22,000 members with funded digital therapy in 12 months,” is available at https://business.amwell.com/resources/2026/case-study/how-discovery-health-scaled-access-to-mental-healthcare-for-22000-members-in-one-year.

About Amwell

Amwell offers health plans and healthcare organizations a single, comprehensive, technology-enabled care platform. We use technology to provide consumers with better access to more convenient, affordable, and effective care. The Amwell Platform includes software and services that power many clinical programmes from Amwell and our growing number of partners. Our platform allows consumers to experience unified, personalised, and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programmes become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions while delivering dependable outcomes.

The platform's digital mental health module, SilverCloud® by Amwell®, provides evidence-based, structured programmes that use the principles of Cognitive Behavioural Therapy and can be delivered with human guidance to support engagement, clinical improvement, and recovery. SilverCloud has supported more than one million users internationally. In the United States, therapy is not provided by Amwell through SilverCloud; therapy is delivered through Amwell Medical Group® virtual visits with licensed therapists.

For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

About Discovery

Discovery Limited is a South African-founded financial services organisation that operates in the healthcare, life assurance, short-term insurance, banking, savings and investment and wellness markets. Since inception in 1992, Discovery has been guided by a clear core purpose – to make people healthier and to enhance and protect their lives. This has manifested in its globally recognised Vitality Shared-Value insurance model, active in over 37 countries with over 50 million members. The model is exported and scaled through the Global Vitality Network, an alliance of some of the largest insurers across key markets including AIA (Asia), Ping An (China), Sumitomo (Japan), John Hancock (US), Manulife (Canada) and Vitality Life & Health (UK, wholly owned). Discovery trades on the Johannesburg Securities Exchange as DSY.

About Discovery Health Medical Scheme

Discovery Health Medical Scheme is the largest open medical scheme in South Africa and independent from the Discovery Group. As with other medical schemes, Discovery Health Medical Scheme is a non-profit entity that pools all contributions to fund healthcare claims. It is regulated by the Council for Medical Schemes, governed by the Medical Schemes Act, No. 131 of 1998, and administered by Discovery Health (Pty) Ltd. Medical schemes are governed by Boards of Trustees, and belong to the members. The Board of Trustees oversees Discovery Health Medical Scheme. The Principal Officer is Charlotte Mbewu.

Results qualification

These results are derived from an observational causal modelling exercise conducted among members invited to participate in iCBT. Statistical risk adjustment was performed for a wide range of measured demographic, clinical, cost, utilization and mental health-related confounding factors to estimate the association between iCBT activation and subsequent outcomes. These findings should be interpreted as estimated effects of iCBT engagement within the eligible invited population, as opposed to a direct comparison of the effectiveness or cost impact of all other alternative treatment approaches such as medication, psychotherapy, psychiatric care or other treatment pathways.

These results reflect the Discovery Health population and implementation model described in the case study. Results may vary across populations, healthcare systems, and implementation approaches.

Media contact

Press inquiries: [email protected]

Investor contact: Asher Dewhurst [email protected]

Search Investors

Company Logo

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, or your device, and is mostly used to make the site work as you expect. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. Blocking some types of cookies may impact your experience of the site and the services we are able to offer. By clicking ‘Accept all’, you agree to allow us to set cookies for site navigation, usage analysis, and marketing; and to monitor, collect, use, and transmit to and share with third-party vendors, information such as device data, website activity, and information you provide. Privacy Policy

Accept All

Manage Consent Preferences

Strictly Necessary Cookies

Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Cookies Details

Performance Cookies

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Cookie List

Clear

  • checkbox label label

Apply Cancel

Leg.Interest

checkbox label label

checkbox label label

checkbox label label

Reject All

Powered by Onetrust

Prompts

American Well Corporation (ticker AMWL), listed in United States.

ETFs Holding American Well Corporation

ETF Weight in ETF Shares Market value As of
AVSC 0.01% 21,967 $ 249.106K Nov 16, 2026
DFAS 0.00% 64,609 $ 777.246K Nov 12, 2026
DXUV 0.00% 9,260 $ 111.398K Nov 12, 2026
DFSU 0.00% 1,254 $ 15.086K Nov 12, 2026
DFAU 0.00% 910 $ 10.947K Nov 12, 2026
DCOR 0.00% 1,474 $ 17.732K Nov 12, 2026
DFAC 0.00% 1,112 $ 13.377K Nov 12, 2026